Información del producto
BMS 819881 is a pharmacologic agent that has been shown to improve insulin sensitivity in humans. It is an amide protonated molecule that has potential use for the treatment of obesity and metabolic disorders. BMS 819881 binds to the ATP-binding pocket of the insulin receptor and activates its signaling pathway, leading to enhanced insulin sensitivity. This drug also increases proton conductance through the membrane, which may be due to its effects on ion channels or by enhancing lipid metabolism. Pharmacokinetic studies have demonstrated that BMS 819881 is well-tolerated with a safety profile similar to placebo. Clinical studies have shown that this drug can be achieved at doses as low as 0.5 mg per day, which is lower than other pharmacologic agents used for weight loss.
Propiedades químicas
Consulta técnica sobre: 3D-XXB42005 BMS 819881
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
